nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoflurane—CYP2B6—Thiotepa—sarcoma	0.185	0.407	CbGbCtD
Isoflurane—CYP2E1—Dacarbazine—sarcoma	0.104	0.229	CbGbCtD
Isoflurane—CYP2E1—Mitoxantrone—sarcoma	0.0806	0.177	CbGbCtD
Isoflurane—CYP2E1—Etoposide—sarcoma	0.0509	0.112	CbGbCtD
Isoflurane—CYP2B6—Doxorubicin—sarcoma	0.0342	0.0752	CbGbCtD
Isoflurane—KCNK2—mammary gland—sarcoma	0.00662	0.039	CbGeAlD
Isoflurane—GLRB—mammary gland—sarcoma	0.00554	0.0326	CbGeAlD
Isoflurane—Ileus—Thiotepa—sarcoma	0.00396	0.0319	CcSEcCtD
Isoflurane—Necrosis—Dactinomycin—sarcoma	0.00355	0.0286	CcSEcCtD
Isoflurane—ATP2C1—mammary gland—sarcoma	0.00353	0.0208	CbGeAlD
Isoflurane—Ileus—Vincristine—sarcoma	0.00351	0.0283	CcSEcCtD
Isoflurane—GABRP—mammary gland—sarcoma	0.00346	0.0203	CbGeAlD
Isoflurane—Delirium—Thiotepa—sarcoma	0.00326	0.0263	CcSEcCtD
Isoflurane—Necrosis—Mitoxantrone—sarcoma	0.00309	0.0249	CcSEcCtD
Isoflurane—ND1—hematopoietic system—sarcoma	0.0027	0.0159	CbGeAlD
Isoflurane—Laryngospasm—Etoposide—sarcoma	0.0027	0.0217	CcSEcCtD
Isoflurane—KCNK2—tendon—sarcoma	0.00267	0.0157	CbGeAlD
Isoflurane—GABRE—mammary gland—sarcoma	0.00264	0.0155	CbGeAlD
Isoflurane—CALM3—mammary gland—sarcoma	0.0026	0.0153	CbGeAlD
Isoflurane—Necrosis—Etoposide—sarcoma	0.00257	0.0207	CcSEcCtD
Isoflurane—ATP5D—myometrium—sarcoma	0.00254	0.0149	CbGeAlD
Isoflurane—CALM2—endothelium—sarcoma	0.00253	0.0149	CbGeAlD
Isoflurane—CALM1—endothelium—sarcoma	0.00252	0.0148	CbGeAlD
Isoflurane—ATP2C1—myometrium—sarcoma	0.0025	0.0147	CbGeAlD
Isoflurane—ALB—mammary gland—sarcoma	0.00241	0.0142	CbGeAlD
Isoflurane—Hyperkalaemia—Mitoxantrone—sarcoma	0.00238	0.0192	CcSEcCtD
Isoflurane—ND1—smooth muscle tissue—sarcoma	0.00238	0.014	CbGeAlD
Isoflurane—ND1—skin of body—sarcoma	0.00235	0.0138	CbGeAlD
Isoflurane—ATP5D—seminal vesicle—sarcoma	0.00229	0.0135	CbGeAlD
Isoflurane—Hepatic failure—Thiotepa—sarcoma	0.00226	0.0182	CcSEcCtD
Isoflurane—ATP2C1—seminal vesicle—sarcoma	0.00226	0.0133	CbGeAlD
Isoflurane—Hepatic failure—Dactinomycin—sarcoma	0.00225	0.0181	CcSEcCtD
Isoflurane—KCNK2—testis—sarcoma	0.00221	0.013	CbGeAlD
Isoflurane—ATP2C1—hematopoietic system—sarcoma	0.00215	0.0126	CbGeAlD
Isoflurane—ATP5D—connective tissue—sarcoma	0.0021	0.0123	CbGeAlD
Isoflurane—CALM1—mammary gland—sarcoma	0.00203	0.012	CbGeAlD
Isoflurane—KCNA1—tendon—sarcoma	0.00203	0.0119	CbGeAlD
Isoflurane—Hepatic failure—Vincristine—sarcoma	0.00201	0.0162	CcSEcCtD
Isoflurane—Cardiac arrest—Thiotepa—sarcoma	0.00194	0.0156	CcSEcCtD
Isoflurane—ATP5D—smooth muscle tissue—sarcoma	0.00192	0.0113	CbGeAlD
Isoflurane—ND1—lymphoid tissue—sarcoma	0.0019	0.0112	CbGeAlD
Isoflurane—ATP2C1—smooth muscle tissue—sarcoma	0.00189	0.0111	CbGeAlD
Isoflurane—GABRE—myometrium—sarcoma	0.00187	0.011	CbGeAlD
Isoflurane—ATP2C1—skin of body—sarcoma	0.00187	0.011	CbGeAlD
Isoflurane—CALM3—myometrium—sarcoma	0.00184	0.0108	CbGeAlD
Isoflurane—ND1—bone marrow—sarcoma	0.00173	0.0102	CbGeAlD
Isoflurane—GRIA1—testis—sarcoma	0.00172	0.0101	CbGeAlD
Isoflurane—Cardiac arrest—Vincristine—sarcoma	0.00172	0.0138	CcSEcCtD
Isoflurane—GABRE—seminal vesicle—sarcoma	0.00169	0.00996	CbGeAlD
Isoflurane—GABRG3—testis—sarcoma	0.00167	0.00981	CbGeAlD
Isoflurane—CALM3—seminal vesicle—sarcoma	0.00167	0.0098	CbGeAlD
Isoflurane—ATP5D—cardiac atrium—sarcoma	0.00165	0.00973	CbGeAlD
Isoflurane—ATP5D—uterus—sarcoma	0.00164	0.00968	CbGeAlD
Isoflurane—ATP2C1—cardiac atrium—sarcoma	0.00163	0.0096	CbGeAlD
Isoflurane—ATP2C1—uterus—sarcoma	0.00162	0.00955	CbGeAlD
Isoflurane—KCNK2—lymph node—sarcoma	0.0016	0.00943	CbGeAlD
Isoflurane—Ileus—Epirubicin—sarcoma	0.0016	0.0128	CcSEcCtD
Isoflurane—GABRP—uterus—sarcoma	0.00159	0.00936	CbGeAlD
Isoflurane—Hyperglycaemia—Thiotepa—sarcoma	0.00159	0.0128	CcSEcCtD
Isoflurane—Jaundice—Thiotepa—sarcoma	0.00153	0.0123	CcSEcCtD
Isoflurane—Ventricular arrhythmia—Epirubicin—sarcoma	0.00153	0.0123	CcSEcCtD
Isoflurane—ATP2C1—lymphoid tissue—sarcoma	0.00151	0.0089	CbGeAlD
Isoflurane—Hepatobiliary disease—Thiotepa—sarcoma	0.00148	0.0119	CcSEcCtD
Isoflurane—ND1—testis—sarcoma	0.00148	0.00871	CbGeAlD
Isoflurane—Ileus—Doxorubicin—sarcoma	0.00148	0.0119	CcSEcCtD
Isoflurane—CALM2—myometrium—sarcoma	0.00145	0.00852	CbGeAlD
Isoflurane—ATP5D—tendon—sarcoma	0.00144	0.00848	CbGeAlD
Isoflurane—CALM1—myometrium—sarcoma	0.00144	0.00848	CbGeAlD
Isoflurane—Necrosis—Epirubicin—sarcoma	0.00144	0.0116	CcSEcCtD
Isoflurane—ATP2C1—tendon—sarcoma	0.00142	0.00837	CbGeAlD
Isoflurane—Ventricular arrhythmia—Doxorubicin—sarcoma	0.00141	0.0114	CcSEcCtD
Isoflurane—GABRA4—tendon—sarcoma	0.0014	0.00826	CbGeAlD
Isoflurane—Hallucination—Thiotepa—sarcoma	0.0014	0.0113	CcSEcCtD
Isoflurane—ND1—liver—sarcoma	0.0014	0.00824	CbGeAlD
Isoflurane—Hepatitis—Dactinomycin—sarcoma	0.0014	0.0113	CcSEcCtD
Isoflurane—ATP5D—bone marrow—sarcoma	0.0014	0.00821	CbGeAlD
Isoflurane—CALM3—smooth muscle tissue—sarcoma	0.00139	0.0082	CbGeAlD
Isoflurane—CALM2—embryo—sarcoma	0.00139	0.00819	CbGeAlD
Isoflurane—Cardiac arrest—Etoposide—sarcoma	0.00139	0.0112	CcSEcCtD
Isoflurane—CALM1—embryo—sarcoma	0.00139	0.00816	CbGeAlD
Isoflurane—GABRD—testis—sarcoma	0.00138	0.00813	CbGeAlD
Isoflurane—ATP2C1—bone marrow—sarcoma	0.00138	0.00811	CbGeAlD
Isoflurane—Hyperglycaemia—Mitoxantrone—sarcoma	0.00137	0.011	CcSEcCtD
Isoflurane—GLRB—lymph node—sarcoma	0.00134	0.0079	CbGeAlD
Isoflurane—Liver injury—Epirubicin—sarcoma	0.00134	0.0108	CcSEcCtD
Isoflurane—Necrosis—Doxorubicin—sarcoma	0.00133	0.0107	CcSEcCtD
Isoflurane—Jaundice—Mitoxantrone—sarcoma	0.00132	0.0106	CcSEcCtD
Isoflurane—Delirium—Epirubicin—sarcoma	0.00131	0.0106	CcSEcCtD
Isoflurane—GABRB3—connective tissue—sarcoma	0.00131	0.00772	CbGeAlD
Isoflurane—CALM2—seminal vesicle—sarcoma	0.00131	0.0077	CbGeAlD
Isoflurane—Cardiac disorder—Thiotepa—sarcoma	0.00131	0.0105	CcSEcCtD
Isoflurane—GABRA5—testis—sarcoma	0.00128	0.00754	CbGeAlD
Isoflurane—Chills—Thiotepa—sarcoma	0.00126	0.0102	CcSEcCtD
Isoflurane—Arrhythmia—Thiotepa—sarcoma	0.00126	0.0101	CcSEcCtD
Isoflurane—Chills—Dactinomycin—sarcoma	0.00125	0.0101	CcSEcCtD
Isoflurane—Bronchospasm—Etoposide—sarcoma	0.00124	0.01	CcSEcCtD
Isoflurane—CALM2—hematopoietic system—sarcoma	0.00124	0.00732	CbGeAlD
Isoflurane—Hallucination—Vincristine—sarcoma	0.00124	0.01	CcSEcCtD
Isoflurane—Liver injury—Doxorubicin—sarcoma	0.00124	0.01	CcSEcCtD
Isoflurane—CALM1—hematopoietic system—sarcoma	0.00124	0.00728	CbGeAlD
Isoflurane—GABRE—cardiac atrium—sarcoma	0.00122	0.00719	CbGeAlD
Isoflurane—Hepatitis—Mitoxantrone—sarcoma	0.00122	0.00979	CcSEcCtD
Isoflurane—Delirium—Doxorubicin—sarcoma	0.00121	0.00978	CcSEcCtD
Isoflurane—CALM3—cardiac atrium—sarcoma	0.0012	0.00707	CbGeAlD
Isoflurane—CALM2—connective tissue—sarcoma	0.0012	0.00704	CbGeAlD
Isoflurane—CALM3—uterus—sarcoma	0.0012	0.00704	CbGeAlD
Isoflurane—GABRA3—testis—sarcoma	0.00119	0.00702	CbGeAlD
Isoflurane—ATP5D—testis—sarcoma	0.00119	0.00702	CbGeAlD
Isoflurane—CALM1—connective tissue—sarcoma	0.00119	0.00701	CbGeAlD
Isoflurane—ATP2C1—testis—sarcoma	0.00118	0.00693	CbGeAlD
Isoflurane—Cardiac disorder—Vincristine—sarcoma	0.00116	0.00933	CcSEcCtD
Isoflurane—Hiccups—Epirubicin—sarcoma	0.00113	0.00909	CcSEcCtD
Isoflurane—Hepatocellular injury—Epirubicin—sarcoma	0.00113	0.00909	CcSEcCtD
Isoflurane—ATP5D—liver—sarcoma	0.00113	0.00664	CbGeAlD
Isoflurane—Agitation—Thiotepa—sarcoma	0.00113	0.00907	CcSEcCtD
Isoflurane—ATP2C1—liver—sarcoma	0.00111	0.00655	CbGeAlD
Isoflurane—Hyperkalaemia—Epirubicin—sarcoma	0.00111	0.00894	CcSEcCtD
Isoflurane—Jaundice—Etoposide—sarcoma	0.0011	0.00885	CcSEcCtD
Isoflurane—Salivary hypersecretion—Epirubicin—sarcoma	0.0011	0.00883	CcSEcCtD
Isoflurane—CALM2—smooth muscle tissue—sarcoma	0.00109	0.00644	CbGeAlD
Isoflurane—Chills—Mitoxantrone—sarcoma	0.00109	0.00879	CcSEcCtD
Isoflurane—CALM1—smooth muscle tissue—sarcoma	0.00109	0.00641	CbGeAlD
Isoflurane—Arrhythmia—Mitoxantrone—sarcoma	0.00109	0.00875	CcSEcCtD
Isoflurane—CALM2—skin of body—sarcoma	0.00108	0.00636	CbGeAlD
Isoflurane—CALM1—skin of body—sarcoma	0.00108	0.00633	CbGeAlD
Isoflurane—ND1—lymph node—sarcoma	0.00107	0.00631	CbGeAlD
Isoflurane—Cough—Thiotepa—sarcoma	0.00107	0.00862	CcSEcCtD
Isoflurane—Hepatobiliary disease—Etoposide—sarcoma	0.00107	0.00858	CcSEcCtD
Isoflurane—GABRE—tendon—sarcoma	0.00106	0.00626	CbGeAlD
Isoflurane—CALM3—tendon—sarcoma	0.00105	0.00617	CbGeAlD
Isoflurane—Hiccups—Doxorubicin—sarcoma	0.00104	0.00842	CcSEcCtD
Isoflurane—Hepatocellular injury—Doxorubicin—sarcoma	0.00104	0.00842	CcSEcCtD
Isoflurane—Hyperkalaemia—Doxorubicin—sarcoma	0.00103	0.00827	CcSEcCtD
Isoflurane—Salivary hypersecretion—Doxorubicin—sarcoma	0.00101	0.00817	CcSEcCtD
Isoflurane—CALM3—bone marrow—sarcoma	0.00101	0.00597	CbGeAlD
Isoflurane—Agitation—Vincristine—sarcoma	0.000999	0.00805	CcSEcCtD
Isoflurane—GABRB2—testis—sarcoma	0.000973	0.00572	CbGeAlD
Isoflurane—CALM2—cardiac atrium—sarcoma	0.000944	0.00555	CbGeAlD
Isoflurane—CALM1—cardiac atrium—sarcoma	0.000939	0.00553	CbGeAlD
Isoflurane—CALM2—uterus—sarcoma	0.000939	0.00553	CbGeAlD
Isoflurane—Cardiac disorder—Etoposide—sarcoma	0.000939	0.00756	CcSEcCtD
Isoflurane—Hepatic function abnormal—Epirubicin—sarcoma	0.000938	0.00755	CcSEcCtD
Isoflurane—CALM1—uterus—sarcoma	0.000934	0.0055	CbGeAlD
Isoflurane—CYP2B6—hematopoietic system—sarcoma	0.000924	0.00544	CbGeAlD
Isoflurane—Cough—Mitoxantrone—sarcoma	0.000924	0.00744	CcSEcCtD
Isoflurane—CYP2E1—seminal vesicle—sarcoma	0.000912	0.00537	CbGeAlD
Isoflurane—Hepatic failure—Epirubicin—sarcoma	0.000912	0.00735	CcSEcCtD
Isoflurane—Chills—Etoposide—sarcoma	0.000908	0.00731	CcSEcCtD
Isoflurane—GABRE—testis—sarcoma	0.000881	0.00519	CbGeAlD
Isoflurane—CALM2—lymphoid tissue—sarcoma	0.000875	0.00515	CbGeAlD
Isoflurane—CALM1—lymphoid tissue—sarcoma	0.000871	0.00513	CbGeAlD
Isoflurane—Hepatic function abnormal—Doxorubicin—sarcoma	0.000868	0.00699	CcSEcCtD
Isoflurane—CALM3—testis—sarcoma	0.000867	0.0051	CbGeAlD
Isoflurane—CYP2E1—hematopoietic system—sarcoma	0.000867	0.0051	CbGeAlD
Isoflurane—ATP5D—lymph node—sarcoma	0.000865	0.00509	CbGeAlD
Isoflurane—ATP2C1—lymph node—sarcoma	0.000853	0.00502	CbGeAlD
Isoflurane—Hepatic failure—Doxorubicin—sarcoma	0.000844	0.0068	CcSEcCtD
Isoflurane—Hypotension—Vincristine—sarcoma	0.000829	0.00668	CcSEcCtD
Isoflurane—CALM2—tendon—sarcoma	0.000822	0.00484	CbGeAlD
Isoflurane—CALM3—liver—sarcoma	0.00082	0.00483	CbGeAlD
Isoflurane—CALM1—tendon—sarcoma	0.000819	0.00482	CbGeAlD
Isoflurane—Hypotension—Mitoxantrone—sarcoma	0.000807	0.0065	CcSEcCtD
Isoflurane—CYP2B6—skin of body—sarcoma	0.000803	0.00473	CbGeAlD
Isoflurane—ALB—testis—sarcoma	0.000803	0.00473	CbGeAlD
Isoflurane—CALM2—bone marrow—sarcoma	0.000797	0.00469	CbGeAlD
Isoflurane—CALM1—bone marrow—sarcoma	0.000793	0.00467	CbGeAlD
Isoflurane—Body temperature increased—Thiotepa—sarcoma	0.000791	0.00637	CcSEcCtD
Isoflurane—Body temperature increased—Dactinomycin—sarcoma	0.000785	0.00632	CcSEcCtD
Isoflurane—Cardiac arrest—Epirubicin—sarcoma	0.000779	0.00628	CcSEcCtD
Isoflurane—Cough—Etoposide—sarcoma	0.000768	0.00619	CcSEcCtD
Isoflurane—ALB—liver—sarcoma	0.000759	0.00447	CbGeAlD
Isoflurane—GABRB3—testis—sarcoma	0.000747	0.0044	CbGeAlD
Isoflurane—Cardiac arrest—Doxorubicin—sarcoma	0.000721	0.00581	CcSEcCtD
Isoflurane—GABRB3—liver—sarcoma	0.000706	0.00416	CbGeAlD
Isoflurane—Body temperature increased—Vincristine—sarcoma	0.000701	0.00565	CcSEcCtD
Isoflurane—Body temperature increased—Mitoxantrone—sarcoma	0.000683	0.0055	CcSEcCtD
Isoflurane—CALM2—testis—sarcoma	0.000681	0.00401	CbGeAlD
Isoflurane—CALM1—testis—sarcoma	0.000678	0.00399	CbGeAlD
Isoflurane—Hypotension—Etoposide—sarcoma	0.000671	0.00541	CcSEcCtD
Isoflurane—CYP2B6—lymphoid tissue—sarcoma	0.00065	0.00383	CbGeAlD
Isoflurane—GABRA2—lymph node—sarcoma	0.000644	0.00379	CbGeAlD
Isoflurane—CALM2—liver—sarcoma	0.000644	0.00379	CbGeAlD
Isoflurane—CALM1—liver—sarcoma	0.000641	0.00377	CbGeAlD
Isoflurane—Hyperglycaemia—Epirubicin—sarcoma	0.000639	0.00515	CcSEcCtD
Isoflurane—GABRE—lymph node—sarcoma	0.000639	0.00376	CbGeAlD
Isoflurane—Vomiting—Thiotepa—sarcoma	0.000636	0.00512	CcSEcCtD
Isoflurane—Vomiting—Dactinomycin—sarcoma	0.000631	0.00508	CcSEcCtD
Isoflurane—Rash—Thiotepa—sarcoma	0.000631	0.00508	CcSEcCtD
Isoflurane—Dermatitis—Thiotepa—sarcoma	0.00063	0.00508	CcSEcCtD
Isoflurane—CALM3—lymph node—sarcoma	0.000629	0.0037	CbGeAlD
Isoflurane—Rash—Dactinomycin—sarcoma	0.000626	0.00504	CcSEcCtD
Isoflurane—Jaundice—Epirubicin—sarcoma	0.000616	0.00496	CcSEcCtD
Isoflurane—CYP2E1—lymphoid tissue—sarcoma	0.00061	0.00359	CbGeAlD
Isoflurane—Hepatobiliary disease—Epirubicin—sarcoma	0.000597	0.00481	CcSEcCtD
Isoflurane—Nausea—Thiotepa—sarcoma	0.000594	0.00479	CcSEcCtD
Isoflurane—Hyperglycaemia—Doxorubicin—sarcoma	0.000591	0.00476	CcSEcCtD
Isoflurane—Nausea—Dactinomycin—sarcoma	0.00059	0.00475	CcSEcCtD
Isoflurane—ALB—lymph node—sarcoma	0.000582	0.00343	CbGeAlD
Isoflurane—CYP2E1—tendon—sarcoma	0.000574	0.00338	CbGeAlD
Isoflurane—Jaundice—Doxorubicin—sarcoma	0.00057	0.00459	CcSEcCtD
Isoflurane—Body temperature increased—Etoposide—sarcoma	0.000568	0.00458	CcSEcCtD
Isoflurane—Hepatitis—Epirubicin—sarcoma	0.000567	0.00457	CcSEcCtD
Isoflurane—Vomiting—Vincristine—sarcoma	0.000564	0.00454	CcSEcCtD
Isoflurane—Rash—Vincristine—sarcoma	0.000559	0.00451	CcSEcCtD
Isoflurane—Dermatitis—Vincristine—sarcoma	0.000559	0.0045	CcSEcCtD
Isoflurane—Hepatobiliary disease—Doxorubicin—sarcoma	0.000553	0.00445	CcSEcCtD
Isoflurane—Vomiting—Mitoxantrone—sarcoma	0.000549	0.00442	CcSEcCtD
Isoflurane—Rash—Mitoxantrone—sarcoma	0.000545	0.00439	CcSEcCtD
Isoflurane—Dermatitis—Mitoxantrone—sarcoma	0.000544	0.00438	CcSEcCtD
Isoflurane—Nausea—Vincristine—sarcoma	0.000527	0.00424	CcSEcCtD
Isoflurane—Cardiac disorder—Epirubicin—sarcoma	0.000526	0.00424	CcSEcCtD
Isoflurane—Hepatitis—Doxorubicin—sarcoma	0.000525	0.00423	CcSEcCtD
Isoflurane—Nausea—Mitoxantrone—sarcoma	0.000513	0.00413	CcSEcCtD
Isoflurane—Chills—Epirubicin—sarcoma	0.000509	0.0041	CcSEcCtD
Isoflurane—Arrhythmia—Epirubicin—sarcoma	0.000506	0.00408	CcSEcCtD
Isoflurane—CYP2B6—testis—sarcoma	0.000506	0.00298	CbGeAlD
Isoflurane—CALM2—lymph node—sarcoma	0.000494	0.00291	CbGeAlD
Isoflurane—CALM1—lymph node—sarcoma	0.000491	0.00289	CbGeAlD
Isoflurane—Cardiac disorder—Doxorubicin—sarcoma	0.000487	0.00392	CcSEcCtD
Isoflurane—CYP2B6—liver—sarcoma	0.000479	0.00282	CbGeAlD
Isoflurane—CYP2E1—testis—sarcoma	0.000475	0.0028	CbGeAlD
Isoflurane—Chills—Doxorubicin—sarcoma	0.000471	0.00379	CcSEcCtD
Isoflurane—Arrhythmia—Doxorubicin—sarcoma	0.000469	0.00377	CcSEcCtD
Isoflurane—Vomiting—Etoposide—sarcoma	0.000457	0.00368	CcSEcCtD
Isoflurane—Agitation—Epirubicin—sarcoma	0.000454	0.00365	CcSEcCtD
Isoflurane—Rash—Etoposide—sarcoma	0.000453	0.00365	CcSEcCtD
Isoflurane—Dermatitis—Etoposide—sarcoma	0.000453	0.00365	CcSEcCtD
Isoflurane—CYP2E1—liver—sarcoma	0.000449	0.00264	CbGeAlD
Isoflurane—Cough—Epirubicin—sarcoma	0.000431	0.00347	CcSEcCtD
Isoflurane—Nausea—Etoposide—sarcoma	0.000427	0.00344	CcSEcCtD
Isoflurane—Agitation—Doxorubicin—sarcoma	0.00042	0.00338	CcSEcCtD
Isoflurane—Cough—Doxorubicin—sarcoma	0.000398	0.00321	CcSEcCtD
Isoflurane—Hypotension—Epirubicin—sarcoma	0.000376	0.00303	CcSEcCtD
Isoflurane—Hypotension—Doxorubicin—sarcoma	0.000348	0.00281	CcSEcCtD
Isoflurane—Body temperature increased—Epirubicin—sarcoma	0.000318	0.00256	CcSEcCtD
Isoflurane—Body temperature increased—Doxorubicin—sarcoma	0.000295	0.00237	CcSEcCtD
Isoflurane—Vomiting—Epirubicin—sarcoma	0.000256	0.00206	CcSEcCtD
Isoflurane—Rash—Epirubicin—sarcoma	0.000254	0.00205	CcSEcCtD
Isoflurane—Dermatitis—Epirubicin—sarcoma	0.000254	0.00204	CcSEcCtD
Isoflurane—Nausea—Epirubicin—sarcoma	0.000239	0.00193	CcSEcCtD
Isoflurane—Vomiting—Doxorubicin—sarcoma	0.000237	0.00191	CcSEcCtD
Isoflurane—Rash—Doxorubicin—sarcoma	0.000235	0.00189	CcSEcCtD
Isoflurane—Dermatitis—Doxorubicin—sarcoma	0.000235	0.00189	CcSEcCtD
Isoflurane—Nausea—Doxorubicin—sarcoma	0.000221	0.00178	CcSEcCtD
Isoflurane—CALM1—Metabolism—PLCG1—sarcoma	3.51e-05	0.00014	CbGpPWpGaD
Isoflurane—CALM2—Metabolism—PLCG1—sarcoma	3.51e-05	0.00014	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—MDM2—sarcoma	3.43e-05	0.000136	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—IL2—sarcoma	3.4e-05	0.000135	CbGpPWpGaD
Isoflurane—CALM3—Neuronal System—HRAS—sarcoma	3.37e-05	0.000134	CbGpPWpGaD
Isoflurane—CALM3—Immune System—FOXO1—sarcoma	3.33e-05	0.000132	CbGpPWpGaD
Isoflurane—CALM3—Immune System—PDGFRB—sarcoma	3.32e-05	0.000132	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—MDM2—sarcoma	3.32e-05	0.000132	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—MDM2—sarcoma	3.32e-05	0.000132	CbGpPWpGaD
Isoflurane—CALM3—Signaling by NGF—HRAS—sarcoma	3.3e-05	0.000131	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—MDM2—sarcoma	3.29e-05	0.000131	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—IL2—sarcoma	3.29e-05	0.000131	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—IL2—sarcoma	3.29e-05	0.000131	CbGpPWpGaD
Isoflurane—CALM3—Immune System—PDGFRA—sarcoma	3.27e-05	0.00013	CbGpPWpGaD
Isoflurane—CALM1—Neuronal System—HRAS—sarcoma	3.26e-05	0.00013	CbGpPWpGaD
Isoflurane—CALM2—Neuronal System—HRAS—sarcoma	3.26e-05	0.00013	CbGpPWpGaD
Isoflurane—CALM2—Immune System—FOXO1—sarcoma	3.22e-05	0.000128	CbGpPWpGaD
Isoflurane—CALM1—Immune System—FOXO1—sarcoma	3.22e-05	0.000128	CbGpPWpGaD
Isoflurane—CALM1—Immune System—PDGFRB—sarcoma	3.21e-05	0.000128	CbGpPWpGaD
Isoflurane—CALM2—Immune System—PDGFRB—sarcoma	3.21e-05	0.000128	CbGpPWpGaD
Isoflurane—CALM1—Signaling by NGF—HRAS—sarcoma	3.19e-05	0.000127	CbGpPWpGaD
Isoflurane—CALM2—Signaling by NGF—HRAS—sarcoma	3.19e-05	0.000127	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—MDM2—sarcoma	3.19e-05	0.000127	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—MDM2—sarcoma	3.19e-05	0.000127	CbGpPWpGaD
Isoflurane—CALM2—Immune System—PDGFRA—sarcoma	3.16e-05	0.000126	CbGpPWpGaD
Isoflurane—CALM1—Immune System—PDGFRA—sarcoma	3.16e-05	0.000126	CbGpPWpGaD
Isoflurane—ALB—Metabolism—PLCG1—sarcoma	3.14e-05	0.000125	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—FLT1—sarcoma	3.09e-05	0.000123	CbGpPWpGaD
Isoflurane—CALM3—Disease—FOXO1—sarcoma	3.07e-05	0.000122	CbGpPWpGaD
Isoflurane—CALM3—Disease—PDGFRB—sarcoma	3.07e-05	0.000122	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PLCG1—sarcoma	3.03e-05	0.000121	CbGpPWpGaD
Isoflurane—CALM3—Disease—PDGFRA—sarcoma	3.02e-05	0.00012	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—FLT1—sarcoma	2.98e-05	0.000119	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—FLT1—sarcoma	2.98e-05	0.000119	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—JUN—sarcoma	2.98e-05	0.000119	CbGpPWpGaD
Isoflurane—CALM2—Disease—FOXO1—sarcoma	2.97e-05	0.000118	CbGpPWpGaD
Isoflurane—CALM1—Disease—FOXO1—sarcoma	2.97e-05	0.000118	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—SRC—sarcoma	2.97e-05	0.000118	CbGpPWpGaD
Isoflurane—CALM1—Disease—PDGFRB—sarcoma	2.97e-05	0.000118	CbGpPWpGaD
Isoflurane—CALM2—Disease—PDGFRB—sarcoma	2.97e-05	0.000118	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—CTNNB1—sarcoma	2.96e-05	0.000118	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—IL2—sarcoma	2.94e-05	0.000117	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PLCG1—sarcoma	2.93e-05	0.000117	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PLCG1—sarcoma	2.93e-05	0.000117	CbGpPWpGaD
Isoflurane—CALM2—Disease—PDGFRA—sarcoma	2.92e-05	0.000116	CbGpPWpGaD
Isoflurane—CALM1—Disease—PDGFRA—sarcoma	2.92e-05	0.000116	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CXCR4—sarcoma	2.91e-05	0.000116	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—VEGFA—sarcoma	2.89e-05	0.000115	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—JUN—sarcoma	2.88e-05	0.000115	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—JUN—sarcoma	2.88e-05	0.000115	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—ATF1—sarcoma	2.88e-05	0.000115	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—SRC—sarcoma	2.87e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—SRC—sarcoma	2.87e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—CTNNB1—sarcoma	2.86e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—CTNNB1—sarcoma	2.86e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—NRAS—sarcoma	2.86e-05	0.000114	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CXCR4—sarcoma	2.82e-05	0.000112	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CXCR4—sarcoma	2.82e-05	0.000112	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—VEGFA—sarcoma	2.8e-05	0.000111	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—VEGFA—sarcoma	2.8e-05	0.000111	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—ATF1—sarcoma	2.79e-05	0.000111	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—ATF1—sarcoma	2.79e-05	0.000111	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—NRAS—sarcoma	2.76e-05	0.00011	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—NRAS—sarcoma	2.76e-05	0.00011	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—SRC—sarcoma	2.67e-05	0.000106	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—CREB1—sarcoma	2.64e-05	0.000105	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—SRC—sarcoma	2.59e-05	0.000103	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—SRC—sarcoma	2.59e-05	0.000103	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—NRAS—sarcoma	2.57e-05	0.000102	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—SRC—sarcoma	2.57e-05	0.000102	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—SRC—sarcoma	2.57e-05	0.000102	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—CREB1—sarcoma	2.56e-05	0.000102	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—CREB1—sarcoma	2.56e-05	0.000102	CbGpPWpGaD
Isoflurane—CALM3—Immune System—KIT—sarcoma	2.54e-05	0.000101	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—VEGFA—sarcoma	2.5e-05	9.96e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—NRAS—sarcoma	2.49e-05	9.9e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—NRAS—sarcoma	2.49e-05	9.9e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—SRC—sarcoma	2.48e-05	9.88e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—SRC—sarcoma	2.48e-05	9.88e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—NRAS—sarcoma	2.47e-05	9.83e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—NRAS—sarcoma	2.47e-05	9.83e-05	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—KRAS—sarcoma	2.46e-05	9.79e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—KIT—sarcoma	2.45e-05	9.76e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—KIT—sarcoma	2.45e-05	9.76e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—CREB1—sarcoma	2.41e-05	9.61e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—NRAS—sarcoma	2.39e-05	9.51e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—NRAS—sarcoma	2.39e-05	9.51e-05	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—KRAS—sarcoma	2.38e-05	9.47e-05	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—KRAS—sarcoma	2.38e-05	9.47e-05	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—EGFR—sarcoma	2.34e-05	9.33e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—KIT—sarcoma	2.34e-05	9.32e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—CREB1—sarcoma	2.34e-05	9.29e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—CREB1—sarcoma	2.34e-05	9.29e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—EGFR—sarcoma	2.27e-05	9.02e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—EGFR—sarcoma	2.27e-05	9.02e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—KIT—sarcoma	2.27e-05	9.01e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—KIT—sarcoma	2.27e-05	9.01e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—IGF1R—sarcoma	2.26e-05	9e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—EGFR—sarcoma	2.25e-05	8.96e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—CREB1—sarcoma	2.23e-05	8.87e-05	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—KRAS—sarcoma	2.21e-05	8.81e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IGF1R—sarcoma	2.19e-05	8.7e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IGF1R—sarcoma	2.19e-05	8.7e-05	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—TP53—sarcoma	2.19e-05	8.7e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—EGFR—sarcoma	2.18e-05	8.66e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—EGFR—sarcoma	2.18e-05	8.66e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—CREB1—sarcoma	2.16e-05	8.58e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—CREB1—sarcoma	2.16e-05	8.58e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—FOXO1—sarcoma	2.15e-05	8.56e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PDGFRB—sarcoma	2.15e-05	8.55e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—KRAS—sarcoma	2.14e-05	8.52e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—KRAS—sarcoma	2.14e-05	8.52e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—KRAS—sarcoma	2.13e-05	8.46e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—KRAS—sarcoma	2.13e-05	8.46e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—PDGFRA—sarcoma	2.11e-05	8.42e-05	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—TP53—sarcoma	2.11e-05	8.41e-05	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—TP53—sarcoma	2.11e-05	8.41e-05	CbGpPWpGaD
Isoflurane—CALM3—Hemostasis—HRAS—sarcoma	2.09e-05	8.32e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—FOXO1—sarcoma	2.08e-05	8.28e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—FOXO1—sarcoma	2.08e-05	8.28e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PDGFRB—sarcoma	2.08e-05	8.27e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PDGFRB—sarcoma	2.08e-05	8.27e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—KRAS—sarcoma	2.06e-05	8.18e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—KRAS—sarcoma	2.06e-05	8.18e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—PDGFRA—sarcoma	2.05e-05	8.14e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—PDGFRA—sarcoma	2.05e-05	8.14e-05	CbGpPWpGaD
Isoflurane—CALM2—Hemostasis—HRAS—sarcoma	2.02e-05	8.05e-05	CbGpPWpGaD
Isoflurane—CALM1—Hemostasis—HRAS—sarcoma	2.02e-05	8.05e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—MDM2—sarcoma	2e-05	7.95e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—IL2—sarcoma	1.95e-05	7.77e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—MDM2—sarcoma	1.93e-05	7.69e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—MDM2—sarcoma	1.93e-05	7.69e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—TP53—sarcoma	1.89e-05	7.52e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—IL2—sarcoma	1.89e-05	7.52e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—IL2—sarcoma	1.89e-05	7.52e-05	CbGpPWpGaD
Isoflurane—CALM3—Innate Immune System—HRAS—sarcoma	1.88e-05	7.49e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—MDM2—sarcoma	1.84e-05	7.34e-05	CbGpPWpGaD
Isoflurane—CALM2—Innate Immune System—HRAS—sarcoma	1.82e-05	7.24e-05	CbGpPWpGaD
Isoflurane—CALM1—Innate Immune System—HRAS—sarcoma	1.82e-05	7.24e-05	CbGpPWpGaD
Isoflurane—ALB—Hemostasis—HRAS—sarcoma	1.81e-05	7.19e-05	CbGpPWpGaD
Isoflurane—CALM3—Adaptive Immune System—HRAS—sarcoma	1.81e-05	7.19e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—IL2—sarcoma	1.78e-05	7.1e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—MDM2—sarcoma	1.78e-05	7.1e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—MDM2—sarcoma	1.78e-05	7.1e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—KDR—sarcoma	1.78e-05	7.08e-05	CbGpPWpGaD
Isoflurane—CALM2—Adaptive Immune System—HRAS—sarcoma	1.75e-05	6.96e-05	CbGpPWpGaD
Isoflurane—CALM1—Adaptive Immune System—HRAS—sarcoma	1.75e-05	6.96e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—JUN—sarcoma	1.74e-05	6.91e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—IL2—sarcoma	1.73e-05	6.87e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—IL2—sarcoma	1.73e-05	6.87e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—CTNNB1—sarcoma	1.72e-05	6.86e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—KDR—sarcoma	1.72e-05	6.85e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—KDR—sarcoma	1.72e-05	6.85e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—JUN—sarcoma	1.68e-05	6.68e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—JUN—sarcoma	1.68e-05	6.68e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—CTNNB1—sarcoma	1.67e-05	6.63e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—CTNNB1—sarcoma	1.67e-05	6.63e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—KIT—sarcoma	1.64e-05	6.53e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—NRAS—sarcoma	1.64e-05	6.53e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—CTNNB1—sarcoma	1.59e-05	6.33e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—KIT—sarcoma	1.59e-05	6.31e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—KIT—sarcoma	1.59e-05	6.31e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—NRAS—sarcoma	1.59e-05	6.31e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—NRAS—sarcoma	1.59e-05	6.31e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CREB1—sarcoma	1.56e-05	6.21e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—SRC—sarcoma	1.56e-05	6.2e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—CTNNB1—sarcoma	1.54e-05	6.12e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—CTNNB1—sarcoma	1.54e-05	6.12e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CREB1—sarcoma	1.51e-05	6.01e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CREB1—sarcoma	1.51e-05	6.01e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—SRC—sarcoma	1.51e-05	5.99e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—SRC—sarcoma	1.51e-05	5.99e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—NRAS—sarcoma	1.5e-05	5.96e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—EGFR—sarcoma	1.49e-05	5.94e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—NRAS—sarcoma	1.45e-05	5.77e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—NRAS—sarcoma	1.45e-05	5.77e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—EGFR—sarcoma	1.45e-05	5.75e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—EGFR—sarcoma	1.45e-05	5.75e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—SRC—sarcoma	1.44e-05	5.72e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—KRAS—sarcoma	1.41e-05	5.62e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—SRC—sarcoma	1.39e-05	5.53e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—SRC—sarcoma	1.39e-05	5.53e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—NRAS—sarcoma	1.38e-05	5.5e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—KRAS—sarcoma	1.37e-05	5.43e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—KRAS—sarcoma	1.37e-05	5.43e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—EGFR—sarcoma	1.37e-05	5.43e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—NRAS—sarcoma	1.34e-05	5.32e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—NRAS—sarcoma	1.34e-05	5.32e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—EGFR—sarcoma	1.32e-05	5.25e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—EGFR—sarcoma	1.32e-05	5.25e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MDM2—sarcoma	1.29e-05	5.14e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—KRAS—sarcoma	1.29e-05	5.13e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—MYC—sarcoma	1.29e-05	5.13e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—EGFR—sarcoma	1.26e-05	5.02e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MDM2—sarcoma	1.25e-05	4.97e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MDM2—sarcoma	1.25e-05	4.97e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—KRAS—sarcoma	1.25e-05	4.96e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—KRAS—sarcoma	1.25e-05	4.96e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—MYC—sarcoma	1.25e-05	4.96e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—MYC—sarcoma	1.25e-05	4.96e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—EGFR—sarcoma	1.22e-05	4.85e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—EGFR—sarcoma	1.22e-05	4.85e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling by GPCR—HRAS—sarcoma	1.2e-05	4.77e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—KRAS—sarcoma	1.19e-05	4.74e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling by GPCR—HRAS—sarcoma	1.16e-05	4.62e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling by GPCR—HRAS—sarcoma	1.16e-05	4.62e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—IL2—sarcoma	1.15e-05	4.59e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—KRAS—sarcoma	1.15e-05	4.58e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—KRAS—sarcoma	1.15e-05	4.58e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CCND1—sarcoma	1.12e-05	4.48e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—JUN—sarcoma	1.12e-05	4.47e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—IL2—sarcoma	1.12e-05	4.44e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—IL2—sarcoma	1.12e-05	4.44e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—CTNNB1—sarcoma	1.11e-05	4.43e-05	CbGpPWpGaD
Isoflurane—CALM3—Immune System—HRAS—sarcoma	1.1e-05	4.36e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CCND1—sarcoma	1.09e-05	4.33e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CCND1—sarcoma	1.09e-05	4.33e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—JUN—sarcoma	1.09e-05	4.32e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—JUN—sarcoma	1.09e-05	4.32e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—CTNNB1—sarcoma	1.08e-05	4.29e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—CTNNB1—sarcoma	1.08e-05	4.29e-05	CbGpPWpGaD
Isoflurane—CALM2—Immune System—HRAS—sarcoma	1.06e-05	4.22e-05	CbGpPWpGaD
Isoflurane—CALM1—Immune System—HRAS—sarcoma	1.06e-05	4.22e-05	CbGpPWpGaD
Isoflurane—CALM3—Disease—HRAS—sarcoma	1.01e-05	4.03e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—SRC—sarcoma	1.01e-05	4.01e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—VEGFA—sarcoma	9.81e-06	3.9e-05	CbGpPWpGaD
Isoflurane—CALM2—Disease—HRAS—sarcoma	9.79e-06	3.9e-05	CbGpPWpGaD
Isoflurane—CALM1—Disease—HRAS—sarcoma	9.79e-06	3.9e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—SRC—sarcoma	9.74e-06	3.88e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—SRC—sarcoma	9.74e-06	3.88e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—NRAS—sarcoma	9.69e-06	3.85e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—VEGFA—sarcoma	9.49e-06	3.77e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—VEGFA—sarcoma	9.49e-06	3.77e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—NRAS—sarcoma	9.37e-06	3.73e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—NRAS—sarcoma	9.37e-06	3.73e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—MYC—sarcoma	9.02e-06	3.59e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—EGFR—sarcoma	8.83e-06	3.51e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—MYC—sarcoma	8.73e-06	3.47e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—MYC—sarcoma	8.73e-06	3.47e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—EGFR—sarcoma	8.54e-06	3.4e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—EGFR—sarcoma	8.54e-06	3.4e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—KRAS—sarcoma	8.34e-06	3.32e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—KRAS—sarcoma	8.06e-06	3.21e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—KRAS—sarcoma	8.06e-06	3.21e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—TP53—sarcoma	7.41e-06	2.95e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—TP53—sarcoma	7.17e-06	2.85e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—TP53—sarcoma	7.17e-06	2.85e-05	CbGpPWpGaD
Isoflurane—CALM3—Signaling Pathways—HRAS—sarcoma	7.09e-06	2.82e-05	CbGpPWpGaD
Isoflurane—CALM2—Signaling Pathways—HRAS—sarcoma	6.86e-06	2.73e-05	CbGpPWpGaD
Isoflurane—CALM1—Signaling Pathways—HRAS—sarcoma	6.86e-06	2.73e-05	CbGpPWpGaD
